Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index

Katherine A. O'Hanlan, Gloria Shining Huang, Lisbeth Lopez, Anne Caroline Garnier

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objective. We studied patients undergoing adnexectomy with total laparoscopic hysterectomy (TLH) for ovarian pathology, over a 6-year period. Methods. Chart abstraction, analyzed by ANOVA, Fisher's Exact Test with significance at P < 0.05, stratifying by body mass index (BMI, kg/m 2: ideal < 25; overweight 25-29.9; obese 30+). Results. Of 354 patients undergoing TLH, 90 cases had adnexal pathology: 69 complex masses, 16 BRCA1/2 mutations, 5 unstaged ovarian carcinomas; 48 having ideal BMI, 26 overweight, and 16 obese. Mean age (51 years) and parity (1.2 children) were similar between BMI groups. Thirty-four percent were nulliparous. All 90 underwent TLH, adnexectomy, washings; with 14 appendectomies, 5 lymphadenectomies, 3 node samplings, 6 omentectomies, 8 ureterolyses, and 1 Burch. Mean surgery duration (156 min), blood loss (152cc), and hospital stay (1.9 days) were similar across BMI groups. Mean nodal yield from each lymphadenectomy was 14, and 2.6 from sampling. Mean size of pelvic masses was 8 cm (range 3-19 cm). There were seven cases of ovarian carcinoma: 2 Stage IA, 1 IB, 2 IC, 1 IIC, 1 IIIB; 1 recurrent breast cancer, 16 adenofibromas, 15 endometriomas, 10 dermoids, and 41 serous/mucinous cystadenomas. Mean complication rate was 6.6% (ns): 1 seroma, 1 hematoma, 1 obstructive adhesions, and 3 urological injuries. All urological injuries were within the first third of patients. Conclusions. TLH appears feasible for women with adnexal pathology regardless of BMI, in an oncological practice. This pilot data can facilitate guidelines for a randomized controlled trial of TLH with TAH and LAVH, and help surgeons avoid our early complications.

Original languageEnglish (US)
Pages (from-to)137-143
Number of pages7
JournalGynecologic Oncology
Volume93
Issue number1
DOIs
StatePublished - Apr 2004

Fingerprint

Hysterectomy
Body Mass Index
Pathology
Lymph Node Excision
Adenofibroma
Serous Cystadenoma
Mucinous Cystadenoma
Carcinoma
Seroma
Dermoid Cyst
Appendectomy
Wounds and Injuries
Endometriosis
Parity
Hematoma
Length of Stay
Analysis of Variance
Randomized Controlled Trials
Guidelines
Breast Neoplasms

Keywords

  • Adnexal pathology
  • Body mass index
  • Total laparoscopic hysterectomy

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index. / O'Hanlan, Katherine A.; Huang, Gloria Shining; Lopez, Lisbeth; Garnier, Anne Caroline.

In: Gynecologic Oncology, Vol. 93, No. 1, 04.2004, p. 137-143.

Research output: Contribution to journalArticle

O'Hanlan, Katherine A. ; Huang, Gloria Shining ; Lopez, Lisbeth ; Garnier, Anne Caroline. / Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index. In: Gynecologic Oncology. 2004 ; Vol. 93, No. 1. pp. 137-143.
@article{34ace6bc8f50429aae74bd19fb5acaae,
title = "Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index",
abstract = "Objective. We studied patients undergoing adnexectomy with total laparoscopic hysterectomy (TLH) for ovarian pathology, over a 6-year period. Methods. Chart abstraction, analyzed by ANOVA, Fisher's Exact Test with significance at P < 0.05, stratifying by body mass index (BMI, kg/m 2: ideal < 25; overweight 25-29.9; obese 30+). Results. Of 354 patients undergoing TLH, 90 cases had adnexal pathology: 69 complex masses, 16 BRCA1/2 mutations, 5 unstaged ovarian carcinomas; 48 having ideal BMI, 26 overweight, and 16 obese. Mean age (51 years) and parity (1.2 children) were similar between BMI groups. Thirty-four percent were nulliparous. All 90 underwent TLH, adnexectomy, washings; with 14 appendectomies, 5 lymphadenectomies, 3 node samplings, 6 omentectomies, 8 ureterolyses, and 1 Burch. Mean surgery duration (156 min), blood loss (152cc), and hospital stay (1.9 days) were similar across BMI groups. Mean nodal yield from each lymphadenectomy was 14, and 2.6 from sampling. Mean size of pelvic masses was 8 cm (range 3-19 cm). There were seven cases of ovarian carcinoma: 2 Stage IA, 1 IB, 2 IC, 1 IIC, 1 IIIB; 1 recurrent breast cancer, 16 adenofibromas, 15 endometriomas, 10 dermoids, and 41 serous/mucinous cystadenomas. Mean complication rate was 6.6{\%} (ns): 1 seroma, 1 hematoma, 1 obstructive adhesions, and 3 urological injuries. All urological injuries were within the first third of patients. Conclusions. TLH appears feasible for women with adnexal pathology regardless of BMI, in an oncological practice. This pilot data can facilitate guidelines for a randomized controlled trial of TLH with TAH and LAVH, and help surgeons avoid our early complications.",
keywords = "Adnexal pathology, Body mass index, Total laparoscopic hysterectomy",
author = "O'Hanlan, {Katherine A.} and Huang, {Gloria Shining} and Lisbeth Lopez and Garnier, {Anne Caroline}",
year = "2004",
month = "4",
doi = "10.1016/j.ygyno.2003.12.020",
language = "English (US)",
volume = "93",
pages = "137--143",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Selective incorporation of total laparoscopic hysterectomy for adnexal pathology and body mass index

AU - O'Hanlan, Katherine A.

AU - Huang, Gloria Shining

AU - Lopez, Lisbeth

AU - Garnier, Anne Caroline

PY - 2004/4

Y1 - 2004/4

N2 - Objective. We studied patients undergoing adnexectomy with total laparoscopic hysterectomy (TLH) for ovarian pathology, over a 6-year period. Methods. Chart abstraction, analyzed by ANOVA, Fisher's Exact Test with significance at P < 0.05, stratifying by body mass index (BMI, kg/m 2: ideal < 25; overweight 25-29.9; obese 30+). Results. Of 354 patients undergoing TLH, 90 cases had adnexal pathology: 69 complex masses, 16 BRCA1/2 mutations, 5 unstaged ovarian carcinomas; 48 having ideal BMI, 26 overweight, and 16 obese. Mean age (51 years) and parity (1.2 children) were similar between BMI groups. Thirty-four percent were nulliparous. All 90 underwent TLH, adnexectomy, washings; with 14 appendectomies, 5 lymphadenectomies, 3 node samplings, 6 omentectomies, 8 ureterolyses, and 1 Burch. Mean surgery duration (156 min), blood loss (152cc), and hospital stay (1.9 days) were similar across BMI groups. Mean nodal yield from each lymphadenectomy was 14, and 2.6 from sampling. Mean size of pelvic masses was 8 cm (range 3-19 cm). There were seven cases of ovarian carcinoma: 2 Stage IA, 1 IB, 2 IC, 1 IIC, 1 IIIB; 1 recurrent breast cancer, 16 adenofibromas, 15 endometriomas, 10 dermoids, and 41 serous/mucinous cystadenomas. Mean complication rate was 6.6% (ns): 1 seroma, 1 hematoma, 1 obstructive adhesions, and 3 urological injuries. All urological injuries were within the first third of patients. Conclusions. TLH appears feasible for women with adnexal pathology regardless of BMI, in an oncological practice. This pilot data can facilitate guidelines for a randomized controlled trial of TLH with TAH and LAVH, and help surgeons avoid our early complications.

AB - Objective. We studied patients undergoing adnexectomy with total laparoscopic hysterectomy (TLH) for ovarian pathology, over a 6-year period. Methods. Chart abstraction, analyzed by ANOVA, Fisher's Exact Test with significance at P < 0.05, stratifying by body mass index (BMI, kg/m 2: ideal < 25; overweight 25-29.9; obese 30+). Results. Of 354 patients undergoing TLH, 90 cases had adnexal pathology: 69 complex masses, 16 BRCA1/2 mutations, 5 unstaged ovarian carcinomas; 48 having ideal BMI, 26 overweight, and 16 obese. Mean age (51 years) and parity (1.2 children) were similar between BMI groups. Thirty-four percent were nulliparous. All 90 underwent TLH, adnexectomy, washings; with 14 appendectomies, 5 lymphadenectomies, 3 node samplings, 6 omentectomies, 8 ureterolyses, and 1 Burch. Mean surgery duration (156 min), blood loss (152cc), and hospital stay (1.9 days) were similar across BMI groups. Mean nodal yield from each lymphadenectomy was 14, and 2.6 from sampling. Mean size of pelvic masses was 8 cm (range 3-19 cm). There were seven cases of ovarian carcinoma: 2 Stage IA, 1 IB, 2 IC, 1 IIC, 1 IIIB; 1 recurrent breast cancer, 16 adenofibromas, 15 endometriomas, 10 dermoids, and 41 serous/mucinous cystadenomas. Mean complication rate was 6.6% (ns): 1 seroma, 1 hematoma, 1 obstructive adhesions, and 3 urological injuries. All urological injuries were within the first third of patients. Conclusions. TLH appears feasible for women with adnexal pathology regardless of BMI, in an oncological practice. This pilot data can facilitate guidelines for a randomized controlled trial of TLH with TAH and LAVH, and help surgeons avoid our early complications.

KW - Adnexal pathology

KW - Body mass index

KW - Total laparoscopic hysterectomy

UR - http://www.scopus.com/inward/record.url?scp=1842530013&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842530013&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2003.12.020

DO - 10.1016/j.ygyno.2003.12.020

M3 - Article

C2 - 15047227

AN - SCOPUS:1842530013

VL - 93

SP - 137

EP - 143

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -